Eli Lilly’s Obesity Pill There’s more competition in the fast-growing obesity treatment market now that Eli Lilly has introduced its once-daily GLP-1 pill. Lilly’s Foundayo (orforglipron) is the second pill approved by the U.S. Food and Drug Administration (FDA) to treat obesity. In December, the agency approved a pill form of the blockbuster drug Wegovy, … Continue reading “Eli Lilly’s Obesity Pill”
Disclaimer
This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.